ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $25,943,000 | -33.6% | 822,012 | -14.8% | 0.29% | -15.9% |
| Q4 2021 | $39,045,000 | +71.7% | 964,782 | +47.9% | 0.35% | +74.7% |
| Q3 2021 | $22,744,000 | +20.5% | 652,240 | -5.1% | 0.20% | +28.6% |
| Q2 2021 | $18,880,000 | -6.6% | 687,540 | -4.4% | 0.15% | -11.0% |
| Q1 2021 | $20,205,000 | -5.9% | 719,540 | -13.0% | 0.17% | -0.6% |
| Q4 2020 | $21,476,000 | +47.3% | 827,270 | -2.8% | 0.17% | +27.0% |
| Q3 2020 | $14,582,000 | -33.4% | 850,770 | -3.9% | 0.14% | -34.4% |
| Q2 2020 | $21,892,000 | – | 884,870 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |